Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey

Autoimmunity Reviews

Volumn 13, Issue 6, 2014, Pages 630-634

  Terrier, Benjamin ^a   Marie, Isabelle ^b   Launay, David ^c   Lacraz, Adeline ^d   Belenotti, Pauline ^e   de Saint Martin, Luc ^f   Quemeneur, Thomas ^d   Huart, Antoine ^g   Bonnet, Fabrice ^h   Le Guenno, Guillaume ⁱ   Kahn, Jean Emmanuel ^d   Hinschberger, Olivier ^d   Rullier, Patricia ^j   Diot, Elisabeth ^k   Lazaro, Estibaliz ^h   Bridoux, Frank ^l   Zénone, Thierry ^d   Carrat, Fabrice ^m   Hermine, Olivier ^d   Léger, Jean Marc ⁿ   Mariette, Xavier ^o   Senet, Patricia ^p   Plaisier, Emmanuelle ^p   Cacoub, Patrice ^q,r,s,t   more..

^a Université Pierre Descartes   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d Department of Nephrology CH CÔte Basque ^*  (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^f BREST UNIVERSITY HOSPITAL   (France)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^j MONTPELLIER UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HOSPITAL OF TOURS   (France)

^l POITIERS UNIVERSITY HOSPITAL   (France)

^m HÔPITAL SAINT ANTOINE   (France)

ⁿ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^o UNIVERSITÉ PARIS SACLAY   (France)

^p HÔPITAL TENON   (France)

^q SORBONNE UNIVERSITÉ   (France)

^r Sorbonne Université   (France)

^s CNRS   (France)

^t ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

more..

Author keywords

Mixed cryoglobulinemia; Relapse; Vasculitis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB;

ADULT; AGED; ARTHROPATHY; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; FOLLOW UP; FRANCE; GASTROINTESTINAL TRACT; HEALTH SURVEY; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INDUCTION THERAPY; JOINT; KIDNEY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED CRYOGLOBULINEMIA VASCULITIS; OUTCOME ASSESSMENT; PERIPHERAL NERVE; PREDICTION; PURPURA; RELAPSE; REMISSION; RETROSPECTIVE STUDY; REVIEW; SKIN; SKIN NECROSIS; SYSTEMIC VASCULITIS; TREATMENT RESPONSE; VASCULITIS;

MIXED CRYOGLOBULINEMIA; RELAPSE; VASCULITIS;

CRYOGLOBULINEMIA; FOLLOW-UP STUDIES; FRANCE; HUMANS; RECURRENCE; REMISSION INDUCTION; VASCULITIS;

EID: 84896545053     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.11.006     Document Type: Review

References (16)

1. Brouet J.C., Clauvel J.P., Danon F., Klein M., Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974, 57:775-788.
2. Gorevic P.D., Kassab H.J., Levo Y., Kohn R., Meltzer M., Prose P., et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980, 69:287-308.
3. Trejo O., Ramos-Casals M., Garcia-Carrasco M., Yague J., Jimenez S., de la Red G., et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Med (Baltimore) 2001, 80:252-262.
4. Saadoun D., Sellam J., Ghillani-Dalbin P., Crecel R., Piette J.C., Cacoub P. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 2006, 166:2101-2108.
5. Ferri C., Zignego A.L., Pileri S.A. Cryoglobulins. J Clin Pathol 2002, 55:4-13.
6. Visentini M., Conti V., Cristofoletti C., Lazzeri C., Marrapodi R., Russo G., et al. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity. Autoimmun Rev 2013, 12:430-435.
7. Saadoun D., Resche Rigon M., Sene D., Terrier B., Karras A., Perard L., et al. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 2010, 116:326-334. [quiz 504-5].
8. Dammacco F., Tucci F.A., Lauletta G., Gatti P., De Re V., Conteduca V., et al. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood 2010, 116:343-353.
9. Pietrogrande M., De Vita S., Zignego A.L., Pioltelli P., Sansonno D., Sollima S., et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011, 10:444-454.
10. Ferri C., Cacoub P., Mazzaro C., Roccatello D., Scaini P., Sebastiani M., et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev 2011, 11:48-55.
11. Visentini M., Ludovisi S., Petrarca A., Pulvirenti F., Zaramella M., Monti M., et al. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection. Autoimmun Rev 2011, 10:714-719.
12. Terrier B., Saadoun D., Sene D., Sellam J., Perard L., Coppere B., et al. Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term follow-up study of thirty-two patients. Arthritis Rheum 2009, 60:2531-2540.
13. Terrier B., Krastinova E., Marie I., Launay D., Lacraz A., Belenotti P., et al. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood 2012, 119:5996-6004.
14. Terrier B., Carrat F., Krastinova E., Marie I., Launay D., Lacraz A., et al. Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey. Ann Rheum Dis 2012, 72(3):374-380.
15. Jennette J.C., Falk R.J. Small-vessel vasculitis. N Engl J Med 1997, 337:1512-1523.
16. Saadoun D., Resche-Rigon M., Thibault V., Piette J.C., Cacoub P. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term follow-up study. Arthritis Rheum 2006, 54:3696-3706.